DrugPatentWatch Database Preview
Rubicon Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has twenty approved drugs.
Summary for Rubicon
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 20 |
Drugs and US Patents for Rubicon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 077747-002 | Apr 9, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | CARVEDILOL | carvedilol | TABLET;ORAL | 078165-001 | Sep 5, 2007 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-001 | Oct 28, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-001 | Aug 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-003 | Aug 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Rubicon | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 202887-002 | Jun 17, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| Rubicon | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170-002 | May 31, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
